Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathway.

Abstract

Elucidating oncogenic pathways in prostate cancer is an arduous task. In this issue of Cancer Cell, Yu and colleagues show that repression of Adrenergic Receptor Beta-2 gene expression by Enhancer of Zeste 2 results in acquisition of transforming activities. It is interesting that these activities point to a role for GTPases as important regulators of… (More)

Topics

  • Presentations referencing similar topics